Acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Ca... — RxCUI 993943
RxNorm drug concept · Semantic clinical drug
RxCUI 993943
Semantic clinical drug · SCD
● Current RxNorm concept 7 FDA products
14 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI993943
Official nameAcetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
FDA products mapped7
Package NDCs mapped14
Reported Medicaid activity (SDUD)6,347 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
- Why am I getting acetaminophen through an IV instead of just taking a pill?
- Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
- The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...
🕸️ Concept Web — How Acetaminophen 325 MG / butalbital 50 MG / caffei... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
RxCUI 993943 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 6
The active substance itself — no strength, form, or brand attached yet.
-
Acetaminophen
161IN -
Butalbital
19860IN -
Caffeine
1886IN -
Codeine
2670IN -
Acetaminophen / butalbital / caffeine / codeine
689561MIN -
Codeine phosphate
2672PIN
-
Acetaminophen
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetaminophen / butalbital / caffeine / codeine Oral Capsule
374830SCDF -
Acetaminophen / butalbital / caffeine / codeine phosphate Oral Capsule
2648123SCDFP -
Acetaminophen / butalbital / caffeine / codeine Oral Product
1152250SCDG -
Acetaminophen / butalbital / caffeine / codeine Pill
1152251SCDG -
Acetaminophen / butalbital / caffeine / codeine phosphate Oral Product
2660619SCDGP -
Acetaminophen / butalbital / caffeine / codeine phosphate Pill
2661139SCDGP -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Acetaminophen / butalbital / caffeine / codeine Oral Capsule
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetaminophen 325 MG
315263SCDC -
Butalbital 50 MG
317309SCDC -
Caffeine 40 MG
317310SCDC -
Codeine phosphate 30 MG
993780SCDC
-
Acetaminophen 325 MG
Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Acetaminophen 325 MG
SCDC · 315263 -
Butalbital 50 MG
SCDC · 317309 -
Caffeine 40 MG
SCDC · 317310 -
Codeine phosphate 30 MG
SCDC · 993780 -
Acetaminophen / butalbital / caffeine / codeine Oral Capsule
SCDF · 374830 -
Acetaminophen / butalbital / caffeine / codeine phosphate Oral Capsule
SCDFP · 2648123 -
Acetaminophen / butalbital / caffeine / codeine Oral Product
SCDG · 1152250 -
Acetaminophen / butalbital / caffeine / codeine Pill
SCDG · 1152251 -
Acetaminophen / butalbital / caffeine / codeine phosphate Oral Product
SCDGP · 2660619 -
Acetaminophen / butalbital / caffeine / codeine phosphate Pill
SCDGP · 2661139
📦 FDA Products & Package NDCs
7 products · 14 package NDCs
14 package NDCs map to RxCUI 993943 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-0650-25 | 100 CAPSULE in 1 BOTTLE (0054-0650-25) | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Hikma Pharmaceuticals USA Inc. | 2022-05-09 |
| 00054-3000-01 | 100 CAPSULE in 1 BOTTLE (0054-3000-01) | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Hikma Pharmaceuticals USA Inc. | 2022-05-09 |
| 00591-3220-01 | 100 CAPSULE in 1 BOTTLE (0591-3220-01) | Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate | Actavis Pharma, Inc. | 2003-09-18 |
| 51991-0073-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-073-01) | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Breckenridge Pharmaceutical, Inc. | 2004-07-01 |
| 71335-0194-01 | 20 CAPSULE in 1 BOTTLE (71335-0194-1) | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Bryant Ranch Prepack | 2021-12-27 |
| 71335-0194-02 | 90 CAPSULE in 1 BOTTLE (71335-0194-2) | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Bryant Ranch Prepack | 2019-08-30 |
| 71335-0194-03 | 30 CAPSULE in 1 BOTTLE (71335-0194-3) | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Bryant Ranch Prepack | 2021-12-27 |
| 71335-0194-04 | 60 CAPSULE in 1 BOTTLE (71335-0194-4) | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Bryant Ranch Prepack | 2021-12-13 |
| 71335-0194-05 | 100 CAPSULE in 1 BOTTLE (71335-0194-5) | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Bryant Ranch Prepack | 2021-12-27 |
| 71335-0194-06 | 15 CAPSULE in 1 BOTTLE (71335-0194-6) | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Bryant Ranch Prepack | 2021-12-27 |
| 71335-0194-07 | 18 CAPSULE in 1 BOTTLE (71335-0194-7) | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Bryant Ranch Prepack | 2021-12-27 |
| 72162-1591-02 | 20 CAPSULE in 1 BOTTLE, PLASTIC (72162-1591-2) | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Bryant Ranch Prepack | 2024-04-04 |
| 79739-6670-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (79739-6670-1) | Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate | LGM PHARMA SOLUTIONS, LLC | 2004-06-10 |
| 79739-6670-05 | 500 CAPSULE in 1 BOTTLE, PLASTIC (79739-6670-5) | Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate | LGM PHARMA SOLUTIONS, LLC | 2004-06-10 |
Observed labelers:
Bryant Ranch Prepack (8) ·
Hikma Pharmaceuticals USA Inc. (2) ·
LGM PHARMA SOLUTIONS, LLC (2) ·
Actavis Pharma, Inc. (1) ·
Breckenridge Pharmaceutical, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.